Zymaxid Approval History
Zymaxid (gatifloxacin ophthalmic) is a fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.
Development History and FDA Approval Process for Zymaxid
|May 19, 2010||Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.